Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of RTS,S/AS02A Malaria Vaccine in Mozambican Children
NCT00323622Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2005
- Primary completion
- May 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of RTS,S in malaria, sponsored by GSK. Started Apr 2005; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00323622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323622.